optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
Published 3 years ago • 90 plays • Length 4:34Download video MP4
Download video MP3
Similar videos
-
0:50
maintenance therapy for patients with advanced urothelial carcinoma
-
1:26
sequencing and treatment strategies in advanced urothelial carcinoma
-
3:37
optimal treatment strategies for patients with metastatic urothelial carcinoma
-
1:58
enfortumab vedotin for the treatment of advanced urothelial cancer
-
1:11
maintenance therapy for bladder cancer
-
2:50
avelumab maintenance for urothelial cancer
-
2:17
optimizing treatment options for patients with muscle-invasive urothelial carcinoma
-
2:31
key immunotherapy combinations for urothelial cancer
-
56:13
advanced/metastatic urothelial carcinoma: understanding novel immunotherapy maintenance strategies
-
1:12
javelin bladder 100: avelumab maintenance for metastatic or locally advanced bladder cancer
-
55:13
advanced/metastatic urothelial carcinoma: understanding novel immunotherapy maintenance strategies
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
44:20
systemic therapies for advanced urothelial cancer
-
0:30
enfortumab vedotin plus pembrolizumab for advanced urothelial carcinoma
-
0:44
antibody-drug conjugates for advanced bladder cancer
-
41:14
auau podcast: sequencing of agents and combination of treatment options for bladder cancer
-
0:57
current and upcoming treatment strategies for upper tract urothelial cancer
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
1:27
a promising future for gemcitabine-oxaliplatin in cisplatin-unfit advanced urothelial carcinoma